Lupin concludes third edition of medical symposiums for Indian urology community

Mumbai: Pharma major Lupin Limited (Lupin) recently announced that it has successfully concluded the third edition of its series of medical symposiums for the Indian urology community.

The latest edition, titled Masterclass: Best of EAU19, was organised in collaboration with the European Association of Urology (EAU) across four cities — Mumbai, New Delhi, Chennai and Kolkata — from December 18-22, 2019 and saw an impressive turnout of 550 urologists in attendance. It also marked the second consecutive year of Lupin's collaboration with the EAU for organising the Masterclass.

This Masterclass leveraged the best of the Annual EAU Congress and enabled discussions around the latest clinical practices and key innovations in the field of urology. It also acquainted urology practitioners in India with the advancements made globally in this field and shared ideas to apply new best practices for patients in India.

The European Association of Urology (EAU) is a non-profit organisation which supports medical professionals working in the field of urology through many of its scientific, professional, educational and awareness-building initiatives. The overarching mission is to raise the level of urological care in Europe, and for many years this has been done through educational and scientific programmes aimed at urologists. Today the EAU represents more than 18,000 medical professionals working in Europe and beyond its borders.

Read also: Lupin gets 2 observations from USFDA for Nagpur facility

Speakers at the event included globally renowned specialists such as Prof. Christopher Chapple from Sheffield U.K., an expert in functional urology; Prof. Marko Babjuk from Charles University, Prague, Cezch Republic; Prof. Maarten Albersen, Assistant Professor and adjunct head of clinic in Urology, University Hospitals Leuven; and Prof. Nikolaos Grivas, Netherlands Cancer Institute, Department of Urology.

Read also: Lupin appoints J Alan Butcher as Chief Corporate Development Officer